Rationale and design of the effects of EMpagliflozin on left ventricular DIAstolic function in diabetes (EmDia) study
Conclusion
By evaluating the short-term effect of empagliflozin with a comprehensive biobanking program, the EmDia Study offers an opportunity to primarily assess the effects on diastolic function but also to examine effects on clinical and molecular cardiovascular traits.
Trial registration
ClinicalTrials.gov; NCT02932436. Registration date, 2016/10/13.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Trial design Source Type: research
More News: Brain | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Empagliflozin | Endocrinology | Heart | Heart Failure | Jardiance | Neurology | Nutrition | Sodium | Study